| scholarly article | Q13442814 |
| P50 | author | Katharina Domschke | Q21264133 |
| Volker Arolt | Q110551284 | ||
| Udo Dannlowski | Q38640593 | ||
| P2093 | author name string | Sachin Patel | |
| Andrea Dlugos | |||
| Katharina Foerster | |||
| Ronny Redlich | |||
| Verena Enneking | |||
| Carolin Redlich | |||
| Dominika Korn | |||
| Matthew Nicholas Hill | |||
| P2860 | cites work | Cannabinoid receptor localization in brain | Q24558751 |
| A rating scale for depression | Q24564540 | ||
| Hub and switches: endocannabinoid signalling in midbrain dopamine neurons | Q24623244 | ||
| Automated Anatomical Labeling of Activations in SPM Using a Macroscopic Anatomical Parcellation of the MNI MRI Single-Subject Brain | Q25855787 | ||
| The neurobiology of anhedonia and other reward-related deficits | Q26853518 | ||
| The endocannabinoid system in energy homeostasis and the etiopathology of metabolic disorders | Q27009022 | ||
| A neural substrate of prediction and reward | Q27860851 | ||
| Cannabinoids inhibit excitatory neurotransmission in the substantia nigra pars reticulata | Q28377147 | ||
| The assessment of anxiety states by rating | Q29614719 | ||
| An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets | Q29614928 | ||
| Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study | Q29615905 | ||
| The reward circuit: linking primate anatomy and human imaging | Q29619828 | ||
| Endocannabinoid signalling in reward and addiction. | Q30373359 | ||
| Substrate-selective COX-2 inhibition decreases anxiety via endocannabinoid activation | Q30547823 | ||
| Individual and additive effects of the CNR1 and FAAH genes on brain response to marijuana cues. | Q33645739 | ||
| Cannabinoid Regulation of Brain Reward Processing with an Emphasis on the Role of CB1 Receptors: A Step Back into the Future | Q33980198 | ||
| Endogenous cannabinoids mediate long-term synaptic depression in the nucleus accumbens | Q34032832 | ||
| Beautiful faces have variable reward value: fMRI and behavioral evidence | Q34101858 | ||
| A neural basis for social cooperation. | Q34142588 | ||
| The pleasures of play: pharmacological insights into social reward mechanisms | Q34159109 | ||
| Cannabinoid modulation of the dopaminergic circuitry: implications for limbic and striatal output | Q34248777 | ||
| Scales for physical and social anhedonia | Q34465940 | ||
| Cannabinoid modulation of subgenual anterior cingulate cortex activation during experience of negative affect | Q34565978 | ||
| Neuronal localization of cannabinoid receptors in the basal ganglia of the rat. | Q34602111 | ||
| Personality traits as risk factors for treatment-resistant depression | Q34744532 | ||
| Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system | Q34745063 | ||
| Are you gonna leave me? Separation anxiety is associated with increased amygdala responsiveness and volume | Q35063677 | ||
| Different mechanisms for dopaminergic excitation induced by opiates and cannabinoids in the rat midbrain | Q73101567 | ||
| The anticipation and outcome phases of reward and loss processing: A neuroimaging meta-analysis of the monetary incentive delay task | Q88478689 | ||
| Brain activity of anandamide: a rewarding bliss? | Q90524726 | ||
| What Is the Test-Retest Reliability of Common Task-Functional MRI Measures? New Empirical Evidence and a Meta-Analysis | Q96133395 | ||
| Divergent effects of genetic variation in endocannabinoid signaling on human threat- and reward-related brain function | Q35548447 | ||
| Contributions of endocannabinoid signaling to psychiatric disorders in humans: genetic and biochemical evidence | Q35784024 | ||
| Reward Processing in Unipolar and Bipolar Depression: A Functional MRI Study. | Q36059920 | ||
| Common and distinct networks underlying reward valence and processing stages: a meta-analysis of functional neuroimaging studies | Q36090066 | ||
| Serum endocannabinoid content is altered in females with depressive disorders: a preliminary report | Q36174333 | ||
| Acute stress increases circulating anandamide and other N-acylethanolamines in healthy humans | Q36234238 | ||
| Independent presynaptic and postsynaptic mechanisms regulate endocannabinoid signaling at multiple synapses in the ventral tegmental area. | Q36873051 | ||
| Cannabinoid modulation of amygdala reactivity to social signals of threat in humans | Q37132683 | ||
| Genetic variation in components of dopamine neurotransmission impacts ventral striatal reactivity associated with impulsivity. | Q37157279 | ||
| The role of the nucleus accumbens and rostral anterior cingulate cortex in anhedonia: integration of resting EEG, fMRI, and volumetric techniques | Q37201652 | ||
| Altered striatal activation predicting real-world positive affect in adolescent major depressive disorder | Q37239474 | ||
| Low putamen activity associated with poor reward sensitivity in childhood chronic fatigue syndrome | Q37298975 | ||
| Endocannabinoid-mediated control of synaptic transmission | Q37363621 | ||
| Circulating endocannabinoid concentrations and sexual arousal in women | Q37377711 | ||
| Reductions in circulating endocannabinoid levels in individuals with post-traumatic stress disorder following exposure to the World Trade Center attacks | Q37409877 | ||
| The effects of Δ9-tetrahydrocannabinol on the dopamine system. | Q37441554 | ||
| Personality Characteristics as Predictive Factors for the Occurrence of Depressive Disorder | Q37658769 | ||
| Can onset and recovery in depression be predicted by temperament? A systematic review and meta-analysis. | Q37832049 | ||
| Circulating Endocannabinoids: From Whence Do They Come and Where are They Going? | Q38707482 | ||
| Biosynthesis and inactivation of the endocannabinoid 2-arachidonoylglycerol in circulating and tumoral macrophages | Q40935411 | ||
| Coexpression of the cannabinoid receptor type 1 with dopamine and serotonin receptors in distinct neuronal subpopulations of the adult mouse forebrain. | Q43873792 | ||
| Inhibition of GABAergic neurotransmission in the ventral tegmental area by cannabinoids | Q44051647 | ||
| The Hamilton Anxiety Scale: reliability, validity and sensitivity to change in anxiety and depressive disorders | Q44104260 | ||
| Test-retest reliability of longitudinal task-based fMRI: Implications for developmental studies | Q46466921 | ||
| Peripheral Endocannabinoid Responses to Hedonic Eating in Binge-Eating Disorder | Q47162113 | ||
| A Sib-Pair Study of the Temperament and Character Inventory Scales in Major Depression | Q47395467 | ||
| Evidence of an IFN-γ by early life stress interaction in the regulation of amygdala reactivity to emotional stimuli | Q47654399 | ||
| Dose-related effects of delta-9-THC on emotional responses to acute psychosocial stress. | Q47830942 | ||
| Enhanced neural responsiveness to reward associated with obesity in the absence of food-related stimuli | Q48110056 | ||
| Nicotinic facilitation of delta9-tetrahydrocannabinol discrimination involves endogenous anandamide | Q48247701 | ||
| Anandamide administration alone and after inhibition of fatty acid amide hydrolase (FAAH) increases dopamine levels in the nucleus accumbens shell in rats | Q48485540 | ||
| Tracking the hemodynamic responses to reward and punishment in the striatum | Q49049564 | ||
| Cannabinoid receptor 1 (CNR1) gene: impact on antidepressant treatment response and emotion processing in major depression. | Q49157217 | ||
| Dissociable neural responses in human reward systems. | Q51076765 | ||
| Circulating endocannabinoid levels, abdominal adiposity and related cardiometabolic risk factors in obese men. | Q51480872 | ||
| Circulating endocannabinoids and affect regulation in human subjects. | Q53415928 | ||
| A new perspective on cannabinoid signalling: complementary localization of fatty acid amide hydrolase and the CB1 receptor in rat brain | Q64212085 | ||
| Protective effects of elevated anandamide on stress and fear-related behaviors: translational evidence from humans and mice | Q64217985 | ||
| [Psychological and social anhedonia. Evaluation of a research instrument for measuring a basic psychopathologic disorder] | Q69021238 | ||
| P577 | publication date | 2020-10-02 | |
| P1433 | published in | Neuropsychopharmacology | Q2261280 |
| P1476 | title | The endocannabinoid system in humans: significant associations between anandamide, brain function during reward feedback and a personality measure of reward dependence |
Search more.